 Products |
| Catalogue Number |
Products |
CAS No. |
Assay |
| G2771 | Pitavastatin sodium | 574705-92-3 | 95% |
| G2776 | Pitavastatin lactone | 141750-63-2 | 95% |
| G2808 | Bitopertin | 845614-11-1 | 95% |
| G2896 | NVP-231 | 362003-83-6 | 95% |
| G5066 | Basmisanil | 1159600-41-5 | 95% |
| G5406 | Bazedoxifene acetate | 198481-33-3 | 95% |
| G6669 | Alogliptin benzoate | 850649-62-6 | 95% |
| G68108 | (2Z)-4-(3,4-Dichlorophenyl)-2-[[2-(4-methyl-1-piperazinyl)phenyl]methylene]-3-thiomorpholinone | 361343-19-3 | 95% |
| G70331 | Gamithromycin | 145435-72-9 | 95% |
| G72458 | Tirofiban hydrochloride monohydrate | 150915-40-5 | 95% |
| G72773 | Ademetionine disulfate tosylate | 97540-22-2 | 95% |
| G73458 | Canagliflozin Hemihydrate | 928672-86-0 | 95% |
| G74175 | TAK 441 | 1186231-83-3 | 95% |
| G74388 | Dactolisib tosylate | 1028385-32-1 | 95% |
| G74389 | Pexmetinib | 945614-12-0 | 95% |
| G74390 | Pitolisant hydrochloride | 903576-44-3 | 95% |
| G74391 | Ponesimod | 854107-55-4 | 95% |
| G74392 | Treprostinil sodium | 289480-64-4 | 95% |
| G74393 | (1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]indene-2,5-diol | 101692-02-8 | 95% |
| G75268 | 1,1,1,3,3,3-Hexafluoropropan-2-yl 4-(bis(benzo[d][1,3]dioxol-5-yl)(hydroxy)methyl)piperidine-1-carboxylate | 1380424-42-9 | 95% |
| G76657 | EED226 | 2083627-02-3 | 95% |
| G76658 | BLU-554 | 1707289-21-1 | 95% |
| G76659 | H3B-6527 | 1702259-66-2 | 95% |
| G76660 | AZD9496 | 1639042-08-2 | 95% |
| G76661 | (3R,5S,6S,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 1632118-70-7 | 95% |
| G76662 | (3R,5S,6S,7S,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 1632118-69-4 | 95% |
| G76663 | Nazartinib | 1508250-71-2 | 95% |
| G76664 | TEW 7197 | 1352608-82-2 | 95% |
| G76665 | GLPG0187 | 1320346-97-1 | 95% |
| G76666 | Ozanimod | 1306760-87-1 | 95% |
|
|
|
